Oral chemotherapy
(OC)
Patients(n)MPR (%)Optimal adherence: n (%) (MPR >80%)Mean duration (months)
MeanMedian
Abiraterone3910710236 (92%)12 (2–32)
Enzalutamide15989712 (80%)5 (1–13)